Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03733990
Title A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Faron Pharmaceuticals Ltd

hepatocellular carcinoma

colorectal adenocarcinoma

pancreatic ductal adenocarcinoma

estrogen-receptor positive breast cancer

thyroid gland anaplastic carcinoma

gastric adenocarcinoma

ovarian cancer

skin melanoma

uveal melanoma

esophagus adenocarcinoma


gastroesophageal junction adenocarcinoma

ovary serous adenocarcinoma

gallbladder cancer



Age Groups: adult | senior
Covered Countries USA | FRA | ESP

No variant requirements are available.